| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $177.4M | — | +5.0% |
| Cost of Revenue | $36.4M | — | +6.1% |
| R&D Expense | $28.1M | — | +10.8% |
| SG&A Expense | $93.9M | — | +8.3% |
| Operating Income | $6.9M | — | +246.8% |
| Interest Expense | $3.7M | — | -19.2% |
| Pre-tax Income | $5.0M | — | -42.6% |
| Income Tax | $2.1M | — | -46.5% |
| Net Income | $2.9M | — | -39.4% |
| EPS (Basic) | $0.07 | — | -30.0% |
| EPS (Diluted) | $0.07 | — | -30.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $144.3M | -9.0% | -49.1% |
| Short-term Investments | $57.9M | -27.5% | -72.4% |
| Accounts Receivable | $125.6M | +1.3% | +19.9% |
| Inventory | $150.4M | -1.6% | +12.4% |
| Current Assets | $515.0M | -6.0% | -32.2% |
| Total Assets | $1.21B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $25.7M | — | -27.6% |
| Capital Expenditures | $2.7M | — | -68.1% |
| Investing Cash Flow | $19.4M | — | +175.9% |
| Financing Cash Flow | -$59.4M | — | -1883.9% |
| Free Cash Flow | $23.0M | — | -14.7% |
| -23.8% |
| Current Liabilities | $108.8M | -9.8% | -65.4% |
| Long-term Debt | $367.7M | -1.2% | -37.0% |
| Total Liabilities | $554.6M | -3.0% | -29.6% |
| Stockholders' Equity | $653.9M | -5.7% | -18.1% |